# Jared J. Grantham

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jared-j-grantham/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,632 |
| Field | Genetic and Kidney Cyst Diseases |
| h-index | 80 |
| i10-index | 179 |
| OpenAlex ID | https://openalex.org/A5001840552 |
| ORCID iD | https://orcid.org/0000-0003-1450-7438 |
| Works | 229 |

## Researcher papers

- [Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/tolvaptan-in-patients-with-autosomal-dominant-polycystic-kidney-disease/)
- [Volume Progression in Polycystic Kidney Disease](https://scholariq.org/papers/volume-progression-in-polycystic-kidney-disease/)
- [Imaging Classification of Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/imaging-classification-of-autosomal-dominant-polycystic-kidney-disease/)
- [Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/blood-pressure-in-early-autosomal-dominant-polycystic-kidney-disease/)
- [Comprehensive Molecular Diagnostics in Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/comprehensive-molecular-diagnostics-in-autosomal-dominant-polycystic-kidney/)
- [Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort1](https://scholariq.org/papers/renal-structure-in-early-autosomal-dominant-polycystic-kidney-disease-adpkd-the/)
- [Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/angiotensin-blockade-in-late-autosomal-dominant-polycystic-kidney-disease/)
- [Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/predicted-mutation-strength-of-nontruncating-pkd1-mutations-aids-genotype/)
- [Potentially Modifiable Factors Affecting the Progression of Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/potentially-modifiable-factors-affecting-the-progression-of-autosomal-dominant/)
- [Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial](https://scholariq.org/papers/effect-of-tolvaptan-in-autosomal-dominant-polycystic-kidney-disease-by-ckd-stage/)
- [Tolvaptan in Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/tolvaptan-in-autosomal-dominant-polycystic-kidney-disease/)

## Researcher topics

- [Genetic and Kidney Cyst Diseases](https://scholariq.org/topics/genetic-and-kidney-cyst-diseases/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)
- [Pediatric Urology and Nephrology Studies](https://scholariq.org/topics/pediatric-urology-and-nephrology-studies/)
- [Ion Transport and Channel Regulation](https://scholariq.org/topics/ion-transport-and-channel-regulation/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.